Form 8-K - Current report:
SEC Accession No. 0001104659-25-061875
Filing Date
2025-06-24
Accepted
2025-06-24 06:03:41
Documents
37
Period of Report
2025-06-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2518647d1_8k.htm   iXBRL 8-K 29396
2 EXHIBIT 99.1 tm2518647d1_ex99-1.htm EX-99.1 35536
3 EXHIBIT 99.2 tm2518647d1_ex99-2.htm EX-99.2 8710
8 GRAPHIC tm2518647d1_ex99-1img001.jpg GRAPHIC 166571
9 GRAPHIC tm2518647d1_ex99-1img002.jpg GRAPHIC 253032
10 GRAPHIC tm2518647d1_ex99-1img003.jpg GRAPHIC 90051
11 GRAPHIC tm2518647d1_ex99-1img004.jpg GRAPHIC 141094
12 GRAPHIC tm2518647d1_ex99-1img005.jpg GRAPHIC 57524
13 GRAPHIC tm2518647d1_ex99-1img006.jpg GRAPHIC 137389
14 GRAPHIC tm2518647d1_ex99-1img007.jpg GRAPHIC 90658
15 GRAPHIC tm2518647d1_ex99-1img008.jpg GRAPHIC 175115
16 GRAPHIC tm2518647d1_ex99-1img009.jpg GRAPHIC 139042
17 GRAPHIC tm2518647d1_ex99-1img010.jpg GRAPHIC 137934
18 GRAPHIC tm2518647d1_ex99-1img011.jpg GRAPHIC 125131
19 GRAPHIC tm2518647d1_ex99-1img012.jpg GRAPHIC 136320
20 GRAPHIC tm2518647d1_ex99-1img013.jpg GRAPHIC 89344
21 GRAPHIC tm2518647d1_ex99-1img014.jpg GRAPHIC 79074
22 GRAPHIC tm2518647d1_ex99-1img015.jpg GRAPHIC 123633
23 GRAPHIC tm2518647d1_ex99-1img016.jpg GRAPHIC 144189
24 GRAPHIC tm2518647d1_ex99-1img017.jpg GRAPHIC 111060
25 GRAPHIC tm2518647d1_ex99-1img018.jpg GRAPHIC 134442
26 GRAPHIC tm2518647d1_ex99-1img019.jpg GRAPHIC 187058
27 GRAPHIC tm2518647d1_ex99-1img020.jpg GRAPHIC 146366
28 GRAPHIC tm2518647d1_ex99-1img021.jpg GRAPHIC 109567
29 GRAPHIC tm2518647d1_ex99-1img022.jpg GRAPHIC 126620
  Complete submission text file 0001104659-25-061875.txt   4297216

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA limn-20250623.xsd EX-101.SCH 3359
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE limn-20250623_def.xml EX-101.DEF 26585
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE limn-20250623_lab.xml EX-101.LAB 36487
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE limn-20250623_pre.xml EX-101.PRE 25209
39 EXTRACTED XBRL INSTANCE DOCUMENT tm2518647d1_8k_htm.xml XML 5328
Mailing Address 6 CENTERPOINTE DR. #625 LA PALMA CA 90623
Business Address 6 CENTERPOINTE DR. #625 LA PALMA CA 90623 213-273-5453
Liminatus Pharma, Inc. (Filer) CIK: 0001971387 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42626 | Film No.: 251066544
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)